HealthCare Global Enterprises 미래 성장
Future 기준 확인 4/6
HealthCare Global Enterprises (는) 각각 연간 48.2% 및 14.5% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 50.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 14.1% 로 예상됩니다.
주요 정보
48.2%
수익 성장률
50.4%
EPS 성장률
| Healthcare 수익 성장 | 27.3% |
| 매출 성장률 | 14.5% |
| 향후 자기자본 수익률 | 14.1% |
| 애널리스트 커버리지 | Good |
| 마지막 업데이트 | 14 Nov 2024 |
최근 미래 성장 업데이트
HealthCare Global Enterprises Limited Just Missed Earnings - But Analysts Have Updated Their Models
Nov 13
HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next
Feb 11Recent updates
HealthCare Global Enterprises Limited Just Missed Earnings - But Analysts Have Updated Their Models
Nov 13We Take A Look At Why HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation Is Well Earned
Sep 19HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next
Feb 11We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation
Sep 14A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG)
Sep 05HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price
May 17Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet?
Jun 24Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings
Jun 03Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt?
Dec 08What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate?
Jun 25Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares
Mar 14The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On
Mar 03Here's Why HealthCare Global Enterprises (NSE:HCG) Can Afford Some Debt
Jan 27수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 3/31/2027 | 29,517 | 2,010 | 2,345 | 5,301 | 6 |
| 3/31/2026 | 25,682 | 1,165 | 1,382 | 4,406 | 9 |
| 3/31/2025 | 22,559 | 770 | -809 | 3,524 | 8 |
| 9/30/2024 | 20,436 | 570 | 923 | 3,468 | N/A |
| 6/30/2024 | 19,770 | 526 | N/A | N/A | N/A |
| 3/31/2024 | 19,121 | 482 | 989 | 2,846 | N/A |
| 12/31/2023 | 18,592 | 353 | N/A | N/A | N/A |
| 9/30/2023 | 18,140 | 371 | 922 | 2,197 | N/A |
| 6/30/2023 | 17,471 | 309 | N/A | N/A | N/A |
| 3/31/2023 | 16,944 | 293 | 1,184 | 2,516 | N/A |
| 12/31/2022 | 16,174 | 270 | N/A | N/A | N/A |
| 9/30/2022 | 15,507 | -264 | 1,156 | 2,364 | N/A |
| 6/30/2022 | 14,827 | 694 | N/A | N/A | N/A |
| 3/31/2022 | 13,978 | 537 | 1,489 | 2,201 | N/A |
| 12/31/2021 | 13,312 | -544 | N/A | N/A | N/A |
| 9/30/2021 | 12,472 | -379 | 1,089 | 1,510 | N/A |
| 6/30/2021 | 11,431 | -1,633 | N/A | N/A | N/A |
| 3/31/2021 | 10,134 | -1,935 | 851 | 1,205 | N/A |
| 12/31/2020 | 9,858 | -1,349 | N/A | N/A | N/A |
| 9/30/2020 | 9,897 | -1,284 | 751 | 1,271 | N/A |
| 6/30/2020 | 10,202 | -1,284 | N/A | N/A | N/A |
| 3/31/2020 | 10,956 | -1,067 | 223 | 1,301 | N/A |
| 12/31/2019 | 10,832 | -718 | N/A | N/A | N/A |
| 9/30/2019 | 10,541 | -552 | N/A | N/A | N/A |
| 6/30/2019 | 10,210 | -394 | N/A | N/A | N/A |
| 3/31/2019 | 9,787 | -248 | -903 | 985 | N/A |
| 12/31/2018 | 9,430 | -135 | N/A | N/A | N/A |
| 9/30/2018 | 9,004 | -41 | N/A | N/A | N/A |
| 6/30/2018 | 8,661 | 124 | N/A | N/A | N/A |
| 3/31/2018 | 8,307 | 205 | N/A | 978 | N/A |
| 12/31/2017 | 7,909 | 257 | N/A | N/A | N/A |
| 9/30/2017 | 7,608 | 278 | N/A | N/A | N/A |
| 6/30/2017 | 7,237 | 219 | N/A | N/A | N/A |
| 3/31/2017 | 7,001 | 230 | N/A | 913 | N/A |
| 12/31/2016 | 6,705 | 208 | N/A | N/A | N/A |
| 9/30/2016 | 6,392 | 133 | N/A | N/A | N/A |
| 6/30/2016 | 6,081 | 67 | N/A | N/A | N/A |
| 3/31/2016 | 5,842 | -178 | N/A | 732 | N/A |
| 12/31/2015 | 5,611 | -33 | N/A | N/A | N/A |
| 9/30/2015 | 5,494 | 9 | N/A | 763 | N/A |
| 6/30/2015 | 5,323 | 9 | N/A | N/A | N/A |
| 3/31/2015 | 5,194 | 8 | N/A | 597 | N/A |
| 3/31/2014 | 4,513 | -356 | N/A | 514 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: HCG 의 연간 예상 수익 증가율( 48.2% )이 saving rate( 6.7% 보다 높습니다. ).
수익 vs 시장: HCG 의 연간 수익( 48.2% ) Indian 시장( 18% 보다 빠르게 성장할 것으로 예상됩니다. 18% 연간).
고성장 수익: HCG 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.
수익 대 시장: HCG 의 수익(연간 14.5% ) Indian 시장( 10.4% 보다 빠르게 성장할 것으로 예상됩니다. 10.4% 연간).
고성장 수익: HCG 의 수익(연간 14.5% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: HCG 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 14.1 %).